Elena Calvo Cantero

ELE Biotech is a Spanish deep-tech startup developing an accessible molecular test for early screening of Alzheimer’s disease and other tauopathies, paired with AI-driven software for dynamic risk stratification. The mission is to bring early dementia detection into routine clinical pathways, starting in primary care, enabling earlier referrals and better long-term patient planning. The company sits at the intersection of diagnostics, AI and longevity, attracting growing interest from clinicians, laboratories, philanthropies and investors focused on health and aging.